2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Glioblastoma
8
Neoplasms
4
Brain Neoplasms
4
Endometrial Neoplasms
3
Breast Neoplasms
3
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Pediatric Brain Tumor
1
Ovarian Neoplasms
1
Non-alcoholic Fatty Liver Disease
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Kidney Neoplasms
1
Ketogen-based Therapeutic Diet
1
Intermittent Fasting
1
Head and Neck Neoplasms
1
Growth Hormone-Secreting Pituitary Adenoma
1
Glioma
1
Fatty Liver
1
Estrogen Receptor-positive Breast Cancer
1
Drug Resistant Epilepsy
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Autism Spectrum Disorder
1
Adenocarcinoma of Lung
1
Interventions
lanreotide
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Temozolomide
1
Surveys and Questionnaires
1
Solutions
1
Radiosurgery
1
Observation
1
Microarray Analysis
1
Injections
1
Early Intervention, Educational
1
Diet, Mediterranean
1
Diet, Ketogenic
1
DNA Methylation
1
Complementary Therapies
1
Biological Therapy
1
90Y-octreotide, DOTA-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Growth Hormone-Secreting Pituitary Adenoma
×
Diet, Ketogenic
×
Clear all
NCT06949891
2025-04-29
KETOACRO
Erasmus Medical Center
Phase NA
Recruiting
60 enrolled